Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Empower Clinics Inc EPWCF

Empower Clinics Inc. is a Canada-based integrated healthcare and medical device company with multi-disciplinary clinics. The Company provides body and mind wellness for patients through its medical clinics, digital and telemedicine care, medical diagnostics laboratories, and sale of medical devices. Its segments include Health & Wellness, comprising clinic operations, patient visits, and telemedicine services; Diagnostics & Technology, comprising the diagnostic testing services provided by Kai Medical, and the sale of medical equipment by Kai Medical Canada Corp. and MediSure; and Corporate. It is focused on offering clinical trial services, such as clinical trial design, patient recruitment, data management and regulatory compliance for the pharmaceutical, biotechnology and medical device industries. It has two clinical research sites in Dallas, Texas, becoming a site management organization (SMO) with six principal investigators (PI) with multiple clinical trials under application.


GREY:EPWCF - Post by User

Post by shanaallstaron Feb 18, 2021 11:33am
116 Views
Post# 32595897

A potentially "breakthrough therapy".

A potentially "breakthrough therapy".
 
 
Sponsored Post
 
It was stated that CB appear to be one of the potentially searched health trends, even outnumbering searches for veganism, exercise, and even vaccines. In addition, these other companies appear to be finding a niche in the functional foods sector- a sector that is seeing potential to approx. $34.3 billion by 2024 at a CAGR of approximately 8.94% between 2019 and 2024.
 
In some other reports, it was stated that these companies could possibly be well exposed to the psychedelic medicine market, which Eight Capital claim could potentially be approx. $100 billion. In addition to that, US FDA appears to be supportive of psilocybin research. In 2018, for example, the agency recognized psilocybin as a potential “breakthrough therapy” for depression.
 
Check the disclaimer on profile and landing page.
<< Previous
Bullboard Posts
Next >>